Described herein are pharmaceutical packaging devices which protect against oxidative degradation of morphine, hydromorphone, promethazine together with other oxygen-sensitive medicine, these units which includes a syringe with the oxygen permeable idea cap, a hermetically sealed oxygen barrier blister packaging with very lower permeability to oxyg